Endowed with a widespread end-use spectrum, calcium phosphate market has been traversing along a lucrative growth path since many years. By virtue of its exceptional properties, industries such as food, pharmaceutical, agricultural, and animal feed have regarded the product as absolutely indispensable, which in consequence has prompted investors to bet big on the global calcium phosphate market. Recently Simon India Limited and EcoPhos entered into an EPC partnership to set up India’s first green field di-calcium phosphate plant in Gujarat. Reportedly, the plant would be producing 200 kilotons of DCP (di-calcium phosphate) from lower grade rock phosphate. In this ?550 crore worth project, the animal feed phosphate provider Simon India will be aiding EcoPhos with its Engineering and Procurement services. In fact, it has also come to fore that through this MoU, both the parties are planning to establish a mutually beneficial long term relationship that would set up many such sustainable plants over the coming years, adding a new dynamism to the calcium phosphate industry.
Speaking of the commercialization potential of the market, it is imperative to mention that unprecedented advancements in biomedical sector, especially in the field of orthopaedic, has significantly increased the product penetration. When it comes to synthetic bone graft substitutes, one of the most rapidly evolving categories consists of products that are based on tricalcium phosphate and calcium phosphate. Whether in the form of blocks, injectable cements, or morsels, calcium phosphate market has a proven track record of delivering effective and safe bone graft substitutes in clinical applications. Needless to mention, the unprecedented advancements in healthcare technology has tremendously boosted the market profile with newer innovations and breakthroughs.
In this regard, recently U.S. based healthcare giant Anika Therapeutics made its way to the front page with the news of receiving FDA clearance for its injectable HA (hyaluronic acid) bone void filler. According to the company, this bone repair treatment is a settable osteoconductive bone graft substitute made of calcium phosphate, that is designed to fill bone voids. As per industry experts, this new treatment indicates the promising growth opportunities for calcium phosphate industry from healthcare applications.
Calcium phosphate marketplace is also set to amass appreciable gains from pharma sector. Historically, the compound has been extensively deployed in pharmaceutical industry as a binder or filler in some of the most commercialized hard gelatin capsules and compressed tablets, subject to its excellent compressibility and flowability. Its elemental calcium quotient and relatively lower cost undoubtedly add up to its market value. As on today, to name some of the most widely commercialized dosage forms of calcium phosphate-based drugs would include Decadron®, Sudafed®, Benadryl®, Gas-X®, and Ex-Lax®.
Despite the fact that calcium phosphate industry space has been witnessing a slew of new opportunities from the extensive profiling of applications that the compound caters to, food & beverage sector still occupies the helm in terms of global share. As per a recent market assessment report, food& beverage applications procured almost 50% of global calcium phosphate industry in 2017. A large credit of this goes to the growing consumer awareness regarding the benefits of calcium intake in developing bones, muscle nerves, and teeth. It is important to a take a note that regulatory initiatives by renowned international bodies like WHO, with regards to healthy lifestyles and food safety awareness have much to contribute in the industry share.
Without an iota of doubt, this wide application array is certain to leave a commendable impact on calcium phosphate market outlook. However, fluctuating raw material price trends and considerably limited number of phosphate reserves worldwide are two of the major factors triggering a supply demand gap in the business model. Add to it, threat of product substitute with the advancement in material science is another challenge that calcium phosphate market players are presently dealing with. Mergers & acquisitions seem to be one of the major growth tactics adopted by companies to overcome these challenges. Numerous business divestures are launching innovative product manufacturing facilities in a collaborative approach. All in all, augmented by a plethora of transformative trends in myriad end-use domains across major topographies, calcium phosphate industry is forecast to exceed a valuation of USD 850 million by 2024.